Company Profile
MiMedx Stock Price, News & Analysis
- Ticker:
- MDXG
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, MiMedx is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
3.73 USD (+1.63%)
Close
Last updated: June 23, 2026 at 00:00
555.57M USD
Market cap
Why the stock is moving
MDXG is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
MiMedx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, MiMedx is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
MiMedx follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, MiMedx sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
MIMEDX Announces Launch of G4Derm® Plus
Source: MiMedx
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of MiMedx (MDXG)?
MiMedx (MDXG) most recently closed at 3.73 USD, a +1.63% move versus the previous session.
What is the market cap of MiMedx (MDXG)?
MiMedx currently has a market capitalization of 555.57M USD on BioPharmSignal.
What does MiMedx do?
MiMedx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is MDXG stock listed?
MiMedx (MDXG) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, MiMedx is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is MiMedx?
MiMedx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is MiMedx targeting with MiMedx?
MiMedx is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.